Telix Pharmaceuticals (Belgium)
ActiveTelix Pharmaceuticals (Belgium) has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €515k and a net result of €-55k. Equity is growing by ~59.7% per year across the filed fiscal years. Its solvency ranks better than 9% of 3161 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.7% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability28▼-5
Solvency23▲+22
Growth68▼-10
Stability100
Bankruptcy probability, 12 months
0.7%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €25k at 30 days acceptable
Liquidity tight (current ratio 1.48 against 0.49 in 2024), and 99.1% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Nine signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
0.9%
Return on assets
-0.1%
Age of the figures
8 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 21
Relative position
BE, all sectors
reference
Sector 21
higher
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Persistent losses
Two consecutive loss-making years (2023 and 2025); equity fell accordingly. May indicate structural pressure on profitability.
NBB · annual accounts 2025Net result per financial year
18192021232425
2018 to 2025 · latest year -€55k
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 9% of 3161 sector peers (2025).
NBB · sector comparisonPosition among 3161 sector peers
Solvency
better than 9%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-07-2026, 0 days ahead of the deadline.
NBB · 8 filingsDeviation from the deadline
2025
on the day
2024
on the day
2023
30 d late
2022
47 d early
2021
16 d early
2020
34 d late
2019
25 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
12-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, full schema
Turnover
€14.87M▲ 72.4%
2024 · €8.63M
2024: €8.63M
2024 → 2025
EBIT margin
6.8%▼ 2.4pp
2024 · 9.1%
2024: 9.1%
2024 → 2025
Net result
€-55k
2024 · €30k
2018: €15k
2019: €32k
2020: €28k
2021: €64k
2023: €-1k
2024: €30k
2018 → 2025
Working capital
€6.07M
2024 · €-16.25M
2018: €28k
2019: €-80k
2020: €-264k
2021: €-1.96M
2023: €-341k
2024: €-16.25M
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202320242025Trend
Turnover€8.63M€14.87M▲ 72.4%
Equity€88k-€152k▲ 73.3%€540k▲ 256%€570k▲ 5.6%€515k▼ 9.6%
Operating result€41k-€108k▲ 161%€227k▲ 110%€789k▲ 247%€1.01M▲ 28.0%
Net result€28k-€64k▲ 128%€-1k€30k€-55k
Result per fiscal year
Operating resultNet result
The operating result has risen four years in a row; 2025 is 28% above 2024 and is the highest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €57.11M
Fixed assets
€38.47M▲ 19.8%
Current assets
€18.64M▲ 21.3%
Equity and liabilities €57.11M
Equity
€515k▼ 9.6%
Provisions
€6.92M=
Debt
€49.67M▲ 24.2%
The debt ratio rises from 84.2% to 87.0%: debt grows while equity shrinks.
Key figures and ratios
EBITDA
€1.78M▲
2024 · €804k
Cash flow
€718k▲
2024 · €45k
Solvency
0.9%▼
2024 · 1.2%
Current ratio
1.48▲
2024 · 0.49
Quick ratio
1.45▲
2024 · 0.47
Debt / equity
96.36▲
2024 · 70.11
ROE
-10.7%▼
2024 · 5.3%
ROA
-0.1%▼
2024 · 0.1%
Interest coverage
1.53▼
2024 · 2.18
Debt
€49.67M▲
2024 · €39.99M
Debt ≤ 1 year
€12.57M▼
2024 · €31.62M
Debt > 1 year
€37.11M▲
2024 · €8.36M
Income taxes
€193k▲
2024 · €77k
Staff costs
€7.92M▲
2024 · €4.20M
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€47.48M€57.11M▲
Fixed assets21/28€32.11M€38.47M▲
Intangible fixed assets21€5.00M€5.00M=
Tangible fixed assets22/27€27.10M€33.46M▲
Land and buildings22€1€13.30M▲
Plant, machinery and equipment23€45k€6.97M▲
Furniture and vehicles24€18k€695k▲
Other tangible fixed assets26€3k€116k▲
Assets under construction and advance payments27€27.04M€12.38M▼
Financial fixed assets28€6k€6k=
Other financial fixed assets284/8€6k€6k=
Amounts receivable and cash guarantees285/8€6k€6k=
Current assets29/58€15.37M€18.64M▲
Amounts receivable after more than one year29-€73k
Trade receivables290-€73k
Stocks and contracts in progress3€405k€365k▼
Stocks30/36€405k€365k▼
Raw materials and consumables30/31€405k€364k▼
Finished goods33-€663
Amounts receivable within one year40/41€14.42M€16.27M▲
Trade receivables40€11.85M€16.11M▲
Other amounts receivable41€2.56M€159k▼
Cash at bank and in hand54/58€498k€1.90M▲
Deferred charges and accrued income490/1€49k€35k▼
Equity and liabilities
Total equity and liabilities10/49€47.48M€57.11M▲
Equity10/15€570k€515k▼
Contributions10/11€12k€12k=
Reserves13€2k€2k=
Non-distributable reserves130/1€2k€2k=
Reserves not available under the articles1311€2k€2k=
Profit (loss) carried forward14€205k€150k▼
Investment grants15€351k€351k=
Provisions and deferred taxes16€6.92M€6.92M=
Provisions for liabilities and charges160/5€6.92M€6.92M=
Major repairs and maintenance162€6.92M€6.92M=
Amounts payable17/49€39.99M€49.67M▲
Amounts payable after more than one year17€8.36M€37.11M▲
Financial debts170/4€8.36M€7.58M▼
Credit institutions173€8.36M€7.58M▼
Other amounts payable178/9€0€29.53M▲
Amounts payable within one year42/48€31.62M€12.57M▼
Current portion of amounts payable after more than one year42€6.74M€7.22M▲
Trade debts44€2.20M€2.61M▲
Suppliers440/4€2.20M€2.61M▲
Taxes, remuneration and social security45€1.18M€2.74M▲
Taxes450/3€223k€1.72M▲
Remuneration and social security454/9€960k€1.02M▲
Other amounts payable47/48€21.50M€0▼
Accrued charges and deferred income492/3€6k€0▼
Income statement
Code20242025
Operating income70/76A€8.79M€17.26M▲
Turnover70€8.63M€14.87M▲
Change in stocks of work in progress, finished goods and contracts in progress71-€663
Own construction capitalised72-€757k
Other operating income74€159k€1.63M▲
Operating charges60/66A€8.00M€16.26M▲
Goods for resale, raw materials and consumables60€0€438k▲
Purchases600/8€405k€458k▲
Change in stocks: decrease (increase)609€-405k€-20k▲
Services and other goods61€3.60M€6.92M▲
Remuneration, social security and pensions62€4.20M€7.92M▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€15k€773k▲
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€61k
Provisions for liabilities and charges: additions (uses and reversals)635/8€55k€0▼
Other operating charges640/8€136k€144k▲
Non-recurring operating charges66A€0-
Operating profit (loss)9901€789k€1.01M▲
Financial income75/76B€15k€338k▲
Recurring financial income75€15k€338k▲
Income from financial fixed assets750€14k€0▼
Other financial income752/9€2k€338k▲
Financial charges65/66B€696k€1.21M▲
Recurring financial charges65€696k€1.21M▲
Debt charges650€369k€1.17M▲
Other financial charges652/9€327k€40k▼
Profit (loss) for the period before taxes9903€107k€138k▲
Income taxes67/77€77k€193k▲
Taxes670/3€115k€193k▲
Tax adjustments and reversals of tax provisions77€37k€0▼
Profit (loss) for the period9904€30k€-55k▼
Profit (loss) for the period to be appropriated9905€30k€-55k▼
Appropriation of the result
Profit (loss) to be appropriated9906€205k€150k▼
Profit (loss) brought forward from the previous period14P€175k€205k▲
Social balance
Average headcount (FTE)908734.951.0▲
The notes to these accounts (91 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-07
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
2025
31-12
Financial
Weakest financial yearnet €-55k ▼283%
Net result drops to €-55k, the lowest in the series.
31-12
Financial
Liquidity triplescurrent ratio 1.48
Current ratio from 0.49 to 1.48; short-term debt falls from €31.62M to €12.57M.
31-07
NBB filing
Annual accounts filed
fiscal year 2024 · unclassified schema
2024
31-12
Financial
Back to profitnet €30k
Net result €30k after one loss-making year.
30-08
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 30 days late
2023
31-12
Financial
Equity above €500kEq €540k ▲256%
Equity rises from €152k to €540k.
14-06
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
15-07
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
31-12
Financial
Highest result since 2018net €64k ▲128%
Net result €64k, the highest in the series.
31-12
Financial
Equity above €150kEq €152k ▲73.3%
4 profitable years in a row build equity to €152k.
03-09
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 34 days late
2020
06-07
NBB filing
Annual accounts filed
fiscal year 2019 · full schema
2019
11-06
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
no sitting director, no change since 2023
We have established no sitting directors for this company. We derive directors from published Gazette acts; while there are none, or none read, nothing appears here. That does not mean the company has none: the CBE keeps its own list of function holders, which we do not read.
15-08-2023
Melanie FARRIS: Resigned as Director
15-08-2023
Richard VALEIX: Resigned as Director
31-07-2022
Douglas Cubbin: Resigned as Director
17-02-2022
BEHRENBRUCH Christian Peter: Resigned as Director
17-02-2022
Bringing Mind 2 Business: Resigned as Director
Location & real-estate footprint
Registered office, Seneffe · 1 establishment unit since 2018
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue Jules Bordet 557180 SeneffeGround area
1.7 ha
Building footprint
2,365 m²
Parcel 52063E0168/00H000, Wallonia. Linked by address, not a title deed.
1 establishment unit
Telix Pharmaceuticals (Belgium)
since 20182.275.795.786
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 52063E0168/00H000 | Wallonia | 1.7 ha | 1 · 2,365 m² | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Connections & network
4 connected companiesNetwork connections
Shared address
→
Shared address
→
Shared address
→
Shared address
→
Similar companies · same sector, comparable size
YUN
BE 0838.163.142
Niel · Eq €521k
Titamed
BE 0866.408.156
Kontich · Eq €463k
MICROBELCAPS
BE 0454.591.191
Liège · Eq €575k
EFRAX
BE 0654.897.577
Brasschaat · Eq €438k
MEDI IMMO
BE 0534.524.042
Waterloo · Eq €624k
Of 97 companies in sector 21209 we hold annual accounts for 74. 42 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded09-05-2018
Fiscal year end31-12
Activities, NACEBEL
21209Manufacture of basic pharmaceutical products and pharmaceutical preparations
70200Business and other management consultancy
70220Business consulting
21201Manufacture of basic pharmaceutical products and pharmaceutical preparations
Sources
Crossroads Bank for EnterprisesNational Bank · 8 filingsAddress and cadastre registers
Data from official sources, last processed on 12-09-2026. Scores and ratios are computed by Checked and are not a credit decision.